Skip to main content
GILEAD SCIENCES, INC. logo

GILEAD SCIENCES, INC. — Investor Relations & Filings

Ticker · GILD ISIN · US3755581036 LEI · 549300WTZWR07K8MNV44 US Manufacturing
Filings indexed 1,962 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country US United States of America
Listing US GILD

About GILEAD SCIENCES, INC.

https://www.gilead.com/

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.

Recent filings

Filing Released Lang Actions
8-K - GILEAD SCIENCES, INC. (0000882095) (Filer)
Regulatory Filings
2026-04-28 English
144 - GILEAD SCIENCES, INC. (0000882095) (Subject)
Regulatory Filings
2026-03-27 English
SCHEDULE 13G/A - GILEAD SCIENCES, INC. (0000882095) (Subject)
Major Shareholding Notification
2026-03-26 English
ARS - GILEAD SCIENCES, INC. (0000882095) (Filer)
Annual Report
2026-03-20 English
DEFA14A - GILEAD SCIENCES, INC. (0000882095) (Filer)
Regulatory Filings
2026-03-20 English
4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
Director's Dealing
2026-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.